Compare PROF & RWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PROF | RWAY |
|---|---|---|
| Founded | N/A | 2015 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 270.7M | 321.2M |
| IPO Year | 2017 | N/A |
| Metric | PROF | RWAY |
|---|---|---|
| Price | $7.48 | $8.09 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | ★ $12.00 | $11.08 |
| AVG Volume (30 Days) | 145.3K | ★ 414.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 17.57% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $10,680,000.00 | N/A |
| Revenue This Year | $61.09 | N/A |
| Revenue Next Year | $120.94 | $2.96 |
| P/E Ratio | $6.41 | ★ $5.70 |
| Revenue Growth | ★ 48.35 | N/A |
| 52 Week Low | $3.90 | $7.61 |
| 52 Week High | $8.95 | $11.41 |
| Indicator | PROF | RWAY |
|---|---|---|
| Relative Strength Index (RSI) | 55.25 | 37.42 |
| Support Level | $5.31 | N/A |
| Resistance Level | $7.95 | $10.07 |
| Average True Range (ATR) | 0.42 | 0.25 |
| MACD | 0.10 | -0.03 |
| Stochastic Oscillator | 75.38 | 35.40 |
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.
Runway Growth Finance Corp is a specialty finance company focused on providing senior secured loans to high-growth-potential companies in technology, life sciences, healthcare information and services, business services, select consumer services and products, and other high-growth industries. The company has Investments in the United States, Germany, and UK, Canada, Netherlands, with the majority of its portfolio invested in the United States.